Eli Lilly, Adaptimmune, Aurion Biotech, and ImmunityBio had breakthrough medicines and therapies debut in the past year.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Pharmaceuticals industry for Monday, March 24, 2025. Let’s take ...

Its Board recently authorized a new $3 billion share repurchase plan, and Royalty Pharma Plc (NASDAQ:RPRX) intends to repurchase $2 billion in 2025. The company ranks tenth on our list of the 10 ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Blog posts represent the views of CFR fellows and staff and not those of CFR, which takes no institutional positions. Most of the major U.S. pharmaceutical companies (AbbVie, Amgen, Bristol Myers ...

The way the process works is that pharmaceutical companies release a list price for a drug while PBMs negotiate rebates on that price. From there, PBMs can skim money by not passing the full ...

We recently published a list of the 10 Oversold Pharma ... materialization poses a big open question for the pharmaceutical sector as some companies assemble their products in the US after ...

Fast Company's annual list of the World's Most Innovative Companies spotlights organizations across various industries that are driving meaningful change through groundbreaking ideas and ...

We recently compiled a list of the 12 Best Small Cap Pharma ... and the dynamics of the pharmaceutical industry. According to her, the industry might not perform poorly at least in the first ...